Case Study: Bridging the Gap: Navigating the Translation to Clinic in TCR-T Development
Time: 11:30 am
day: DAY ONE TRACK 1 B
Details:
- Key strategies and considerations for translating TCR-T therapies from preclinical development to clinical applications
- The FIH study of an HLA-class II restricted HPV18 E7 specific TCR cloned from a long-term surviving cervical cancer patient
- Beside affinity, what did we learn from TCR-T development?
- Deciding on a preclinical model and data package